Tapentadol-ER for the treatment of diabetic peripheral neuropathy.
Consult Pharm
; 28(10): 672-5, 2013 Oct.
Article
en En
| MEDLINE
| ID: mdl-24129223
Palabras clave
DM = Diabetes mellitus; DPN = Diabetic peripheral neuropathy; Diabetes mellitus; Diabetic peripheral neuropathy; ER = Extended release; Geriatric; MOR-NRI = mu-opiod receptor agonist-norepinephrine reuptake inhibitor; NRS = Numerical rating scale; Nucynta ER; SAE = Serious adverse event; SNRI = Serotonin-norepinephrine reuptake inhibitor; SSRI = Selective-serotonin reuptake inhibitor; TCA = Tricyclic antidepressant; TEAE = Treatment-emergent adverse event; Tapentadol ER
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fenoles
/
Neuropatías Diabéticas
/
Analgésicos Opioides
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Consult Pharm
Asunto de la revista:
FARMACIA
Año:
2013
Tipo del documento:
Article
Pais de publicación:
Estados Unidos